https://www.selleckchem.com/pr....oducts/carfilzomib-p
26; 95%CI, 1.02-1.57) with risk of IPF in the multivariate model. In ever smokers, a dose-response relationship was observed between pack-years of smoking and risk of IPF (HR per 1-pack-year increase, 1.013; 95%CI, 1.009-1.016). Furthermore, an additive and multiplicative interaction was observed between maternal smoking and smoking status, with a relative excess risk resulting from an interaction of 1.00 (95%CI, 0.45-1.54) and a ratio of HR of 1.50 (95%CI, 1.05-2.14). Active and passive tobacco smoking have an independent de
Like
Comment
Share
